CO2 Solutions Inc.

The stock sits in a flat, long-duration base with the 50-day and 200-day moving averages both pinned near the same level. It is trading at the top of its multi-month range, but the broader regime is still a low-liquidity, penny-stock setup rather than a confirmed trend.

No analyst consensus or price target is available, so there is no Street signal to anchor expectations. With no recent rating changes or target revisions, shareholders should treat the name as unloved and largely off the coverage radar.

There are no current estimates, and the last reported earnings history was consistently negative, with EPS of -0.0115 in the final two reported 2019 quarters. The key watch item is whether operating losses stay contained while cash remains available to fund the business.

No recent insider transactions were reported. That leaves no visible discretionary buying or selling signal to interpret, and no evidence of award-related noise either.

Profitability remains weak, with operating margin at -12.5567% and ROA at -0.5825. The balance sheet is the offset: fiscal 2018 cash and equivalents of 5,478,925 against total debt of 1,000,076 left net cash of 4,478,849, while free cash flow was positive at 2,063,394.88.

The company’s enzyme-based carbon-capture niche gives it a differentiated industrial pollution-control story, but it lacks the scale and coverage of larger peers. With no valuation metrics or consensus target, the setup is more speculative than comparable on standard sector multiples.